Early research (Phase 1)Study completedNCT01450839What this trial is testingE2022 Patch Formulation Multiple Dose StudyWho this might be right forHealthy Eisai Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT00329901What this trial is testingImmunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 YearsWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 1,072
Not applicableStudy completedNCT00088712What this trial is testingEvent Related Potentials in Infants and AdultsWho this might be right forHealthyChild Development Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 440
Testing effectiveness (Phase 2)Study completedNCT06134648What this trial is testingStudy of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidateWho this might be right forRespiratory Syncytial Virus InfectionHealthy VolunteersHuman Metapneumovirus Sanofi Pasteur, a Sanofi Company 646
Early research (Phase 1)Study completedNCT02405520What this trial is testingSafety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent VaccineWho this might be right forCondylomata Acuminata Jun Zhang 145
Early research (Phase 1)Ended earlyNCT02254161What this trial is testingMultiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT01154621What this trial is testingAssessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female SubjectsWho this might be right forTolerabilityHealthyElderly AstraZeneca 12
Early research (Phase 1)Study completedNCT06644326What this trial is testingA PK Study of IkT-148009 in Older and Elderly Healthy SubjectsWho this might be right forHealthy ABLi Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01543386What this trial is testingEffects of Curcumin on Vascular ReactivityWho this might be right forHealthy Volunteers (Middle-aged Smokers) University Hospital, Clermont-Ferrand 21
Early research (Phase 1)Study completedNCT01665924What this trial is testingSingle and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy SubjectsWho this might be right forHealthy Lakefront Biotherapeutics NV 36
Post-approval studies (Phase 4)Study completedNCT01356342What this trial is testingImmunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years OldWho this might be right forInfluenza Adimmune Corporation 181
Early research (Phase 1)Study completedNCT02179645What this trial is testingGRC 27864 First in Man, Single Ascending Dose Study in Healthy VolunteersWho this might be right forHealthy Glenmark Pharmaceuticals Ltd. India 76
Early research (Phase 1)Study completedNCT06699628What this trial is testingPhase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly VolunteersWho this might be right forNot Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy SubjectsApathy Integrative Research Laboratories AB 12
Large-scale testing (Phase 3)Study completedNCT06592456What this trial is testingA Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 YearsWho this might be right forChickenpox Vaccines Southeast University, China 1,200
Not applicableLooking for participantsNCT06666660What this trial is testingDaily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged IndividualsWho this might be right forRelatively Healthy Volunteers National University of Singapore 400
Large-scale testing (Phase 3)Study completedNCT00971542What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 778
Large-scale testing (Phase 3)Study completedNCT00617851What this trial is testingStudy to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years OldWho this might be right forInfluenza Novartis Vaccines 1,507
Testing effectiveness (Phase 2)Active Not RecruitingNCT06907511What this trial is testingStudy to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderWho this might be right forPandemic Influenza ImmunizationHealthy Volunteers Sanofi 720
Large-scale testing (Phase 3)Looking for participantsNCT07555392What this trial is testingA Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.Who this might be right forActive Immunisation for Chikungunya Virus Infection Bharat Biotech International Limited 1,000
Testing effectiveness (Phase 2)Study completedNCT02531698What this trial is testingDescribe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 YearsWho this might be right forMENINGOCOCCAL INFECTION Pfizer 400